Artelo Biosciences, Inc. Warrant
ARTLW
ARTLW was delisted on the 17th of June, 2024.
3 hedge funds and large institutions have $33K invested in Artelo Biosciences, Inc. Warrant in 2019 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
50% less capital invested
Capital invested by funds: $66K → $33K (-$33K)
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CH
1
CVI Holdings
Wilmington,
Delaware
| $19K | – | – | – |
|
2
Verition Fund Management
Greenwich,
Connecticut
| $10K | – | – | – |
|
|
AGM
3
Alpine Global Management
New York
| $4K | – | – | – |
|
ARTLW Hedge Fund Activity: Q4 2019 in Review
3 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Artelo Biosciences, Inc. Warrant (ARTLW) for Q4 2019, worth a combined $33K — down 50% from $66K a quarter earlier.
Fund positioning in ARTLW was balanced in Q4 2019: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.
- 3 institutional investors held Artelo Biosciences, Inc. Warrant (ARTLW) as of Q4 2019, unchanged from Q3 2019.
- Funds reported $33K of Artelo Biosciences, Inc. Warrant stock for Q4 2019, down 50% quarter-over-quarter.
- 0 funds opened new Artelo Biosciences, Inc. Warrant positions in Q4 2019 and 0 closed out.
Based on aggregated 13F filings for Q4 2019.